Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Audrey W. Li"'
Publikováno v:
Drug Target Insights, Vol 2013, Iss 7, Pp 9-17 (2013)
Externí odkaz:
https://doaj.org/article/750b1d4b45854641af036fff30f141e5
Publikováno v:
Drug Target Insights, Vol 7, Iss 1 (2013)
Abstract non disponibile
Externí odkaz:
https://doaj.org/article/90efa1ea3231439eb024ae580479ee0d
Autor:
Bruce E. Holbein, Maral Aali, Audrey W. Li, Valerie Chappe, Christian Lehmann, Alexa Caldwell
Publikováno v:
Journal of Cellular Biotechnology. 6:161-170
Iron chelators have been utilized clinically to treat patients with iron overload conditions. There is a growing body of evidence linking iron dysregulation and reactive oxygen species (ROS) overproduction as underlying factors in Cystic Fibrosis (CF
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3c0b114026efc0cb19dad9f2f7c0fdc7
https://doi.org/10.3233/jcb-209011
https://doi.org/10.3233/jcb-209011
Autor:
Anna Semaniakou, Younes Anini, Valerie Chappe, Grayson Gould, Mehrsa Zahiremani, Jamie Paton, Roger P. Croll, Frederic Chappe, Audrey W. Li
Publikováno v:
Journal of Cystic Fibrosis. 20:154-164
Vasoactive Intestinal Peptide (VIP) is the major physiological agonist of the Cystic Fibrosis Transmembrane conductance Regulator (CFTR) chloride channel activity. VIP functions as a neuromodulator and neurotransmitter secreted by neurons innervating
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::329f4e87504f0d1b26c8ea438f6318c3
https://doi.org/10.1016/j.jcf.2020.06.013
https://doi.org/10.1016/j.jcf.2020.06.013
Publikováno v:
FASEB BioAdvances, Vol 2, Iss 1, Pp 33-48 (2020)
FASEB bioAdvances
FASEB bioAdvances
The CFTR chloride channel is regulated by phosphorylation at PKA and PKC consensus sites within its regulatory region (R‐region) through a mechanism, which is still not completely understood. We used a split‐CFTR construct expressing the N‐term
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b47a1243b043da2d67f20ff6c6732c61
https://doaj.org/article/97e81bc996234b8db49e346e2a617ab6
https://doaj.org/article/97e81bc996234b8db49e346e2a617ab6
Publikováno v:
Gene. 539:203-208
We assembled a new set of mRNA sequences from the leg hypodermis transcriptome of the wandering spider, Cupiennius salei. Each sequence was assembled to exhaustion in the 5′ direction to detect all upstream open reading frames (uORFs) both in-frame
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01f0b2e76d07885a530ff3ca7e8eca73
https://doi.org/10.1016/j.gene.2014.01.079
https://doi.org/10.1016/j.gene.2014.01.079
Autor:
Drew DeBay, Audrey W. Li, Chris V. Bowen, Mohammed Althobaiti, Stacy B. O'Blenes, James R. Clarke
Publikováno v:
Drug Target Insights, Vol 2013, Iss 7, Pp 9-17 (2013)
Drug Target Insights
Drug Target Insights, Vol 7 (2013)
Drug Target Insights
Drug Target Insights, Vol 7 (2013)
In clinical studies, skeletal myoblast (SKMB) transplantation late after myocardial infarction (MI) has minimal impact on left ventricular (LV) function. This may be related to our previous observation that the extent of SKMB engraftment is minimal i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::178032d8394c6c90bc5ff9f3c5792ba4
http://www.la-press.com/impact-of-hepatocyte-growth-factor-on-skeletal-myoblast-transplantatio-article-a3663
http://www.la-press.com/impact-of-hepatocyte-growth-factor-on-skeletal-myoblast-transplantatio-article-a3663
Publikováno v:
The Annals of Thoracic Surgery. 89:829-835
In a recent clinical trial, skeletal myoblast (SKMB) transplantation performed late after myocardial infarction (MI) did not improve left ventricular function. We hypothesized that (1) delaying SKMB transplantation until a chronic infarct scar has de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7cacde5b2da888680996ac4d1ca27d2
https://doi.org/10.1016/j.athoracsur.2009.12.007
https://doi.org/10.1016/j.athoracsur.2009.12.007
Autor:
Christie Barclay, Alan G. Casson, Mark Baguma-Nibasheka, Geoffrey A. Porter, Paul R. Murphy, Laurette Geldenhuys, Audrey W. Li, Paul J. Veugelers
Publikováno v:
Clinical Cancer Research. 11:7683-7691
Purpose: The basic fibroblast growth factor (FGF-2) gene is bidirectionally transcribed to generate overlapping sense and antisense (FGF-AS) mRNAs. FGF-AS has been implicated in the post-transcriptional regulation of FGF-2 expression. The aim of this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d0623286507e36e97732a1a2ddf928c
https://doi.org/10.1158/1078-0432.ccr-05-0771
https://doi.org/10.1158/1078-0432.ccr-05-0771
Autor:
Audrey W. Li, Paul R. Murphy, Mark Baguma-Nibasheka, Alan G. Casson, Mohammed S. Osman, Catherine K.L. Too, Laurette Geldenhuys
Publikováno v:
Leukemia Research. 29:423-433
Fibroblast growth factor-2 (FGF-2) is a growth and survival factor whose expression is elevated in many hematopoietic malignancies. A natural antisense RNA (FGF-AS) has been implicated in the posttranscriptional regulation of FGF-2 mRNA expression. W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::926d179f52f9905dd1ca14a6e7d7ec51
https://doi.org/10.1016/j.leukres.2004.09.006
https://doi.org/10.1016/j.leukres.2004.09.006